Who owns the AMYRIAD THERAPEUTICS trademark?

The AMYRIAD THERAPEUTICS trademark is owned by AmyriAD Therapeutics B.V..

What is the serial number for AMYRIAD THERAPEUTICS?

The USPTO serial number for AMYRIAD THERAPEUTICS is 97107538.

What is the registration number for AMYRIAD THERAPEUTICS?

AMYRIAD THERAPEUTICS is registered under USPTO registration number 0.

AMY

USPTO Trademark Record

ABANDONED

AMYRIAD THERAPEUTICS

Q: What class is the AMYRIAD THERAPEUTICS trademark registered in?

The AMYRIAD THERAPEUTICS trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 042 (Scientific, technology & SaaS services).

SN 97107538·Reg 0·Filed Nov 03, 2021

Owner AmyriAD Therapeutics B.V.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.; Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

AMYRIAD THERAPEUTICS (Serial No. 97107538), Registration No. 0, is a abandoned US trademark filed on Nov 03, 2021 by AmyriAD Therapeutics B.V.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 042 (Scientific, technology & SaaS services).

Mark Intelligence

AMYRIAD THERAPEUTICS (Reg. #0) is an abandoned US trademark that was filed in 2021 but has since been abandoned. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations) and Class 042 (Scientific, technology & SaaS services) respectively. Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs....

FILED

Nov 03, 2021

SERIAL

97107538

REG#

REGISTERED

Dec 31, 1969

Owner

Applicant

AmyriAD Therapeutics B.V.

Entity

Not Provided

Address

444 S. Flower Street, Suite 1300, Los Angeles, CA, 90071

Country

Attorney

NameJohn Paul Oleksiuk

Law firm

John Paul Oleksiuk COOLEY LLP

Docket

344896-20000

Address

1299 PENNSYLVANIA AVENUE, NW, SUITE 700, WASHINGTON, DC 20004, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusABANDONED

Filing DateNov 03, 2021

Serial Number97107538

Registration No.0

Registration DateDec 31, 1969

Status DateJan 02, 2026

Mark TypeStandard characters

Attorney Docket344896-20000

Status DescriptionDead and abandoned due to failure to respond

Filing Signals

FILED

2021

YEARS AGO

CLASSES

MADRID FILINGS

—

Search 15M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

Class 042Scientific, technology & SaaS services

US codes: 100, 101

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

34 events

ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE

Jan 02, 2026

ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND

Jan 02, 2026

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

Sep 09, 2025

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

Sep 09, 2025

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

SUSPENSION INQUIRY WRITTEN

Jun 11, 2025

SUSPENSION INQUIRY WRITTEN

INQUIRY TO SUSPENSION E-MAILED

Jun 11, 2025

INQUIRY TO SUSPENSION E-MAILED

NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED

Jun 11, 2025

NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

Jun 08, 2025

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

LETTER OF SUSPENSION E-MAILED

Dec 06, 2024

LETTER OF SUSPENSION E-MAILED

SUSPENSION LETTER WRITTEN

Dec 06, 2024

SUSPENSION LETTER WRITTEN

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

Dec 06, 2024

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Nov 15, 2024

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Nov 15, 2024

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Nov 15, 2024

TEAS/EMAIL CORRESPONDENCE ENTERED

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

Aug 14, 2024

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

Aug 14, 2024

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

NON-FINAL ACTION E-MAILED

May 16, 2024

NON-FINAL ACTION E-MAILED

NON-FINAL ACTION WRITTEN

May 16, 2024

NON-FINAL ACTION WRITTEN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

May 16, 2024

NOTIFICATION OF NON-FINAL ACTION E-MAILED

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

Apr 15, 2024

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

ASSIGNED TO EXAMINER

Jan 12, 2024

ASSIGNED TO EXAMINER

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

Oct 13, 2023

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

SUSPENSION LETTER WRITTEN

Feb 27, 2023

SUSPENSION LETTER WRITTEN

LETTER OF SUSPENSION E-MAILED

Feb 27, 2023

LETTER OF SUSPENSION E-MAILED

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

Feb 27, 2023

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

TEAS/EMAIL CORRESPONDENCE ENTERED

Feb 18, 2023

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Feb 17, 2023

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Feb 17, 2023

CORRESPONDENCE RECEIVED IN LAW OFFICE

NON-FINAL ACTION WRITTEN

Aug 19, 2022

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Aug 19, 2022

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Aug 19, 2022

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Aug 12, 2022

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Nov 15, 2021

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Nov 06, 2021

NEW APPLICATION ENTERED

AMYRIAD THERAPEUTICS

Get pre-filing clearance

Search 15M+ trademarks

Run a conflict check

Other Marks by AmyriAD Therapeutics B.V.

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by John Paul Oleksiuk

Resources

Company